Legacy Advisors’s Elanco Animal Health ELAN Stock Holding History

Legacy Advisors’s Portfolio ELAN Stock Details ELAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-139	Closed	-$5K	–	175
2019 Q2	$5K	Buy	+139	New	+$4.51K	﹤0.01%	326

Other funds holding ELAN

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

AAMU

Amundi Asset Management US Boston, Massachusetts $131B AUM 73.57% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Legacy Advisors's ELAN Position: Q3 2019 in Review

Legacy Advisors sold out of Elanco Animal Health (ELAN) in Q3 2019, closing a stake of 139 shares — an estimated $5K sold.

Legacy Advisors first reported a position in ELAN in Q2 2019 and held it in 1 quarter. The position peaked at $5K in Q2 2019. 376 funds tracked by Wall St. Rank hold ELAN as of Q3 2019.

Legacy Advisors reported no remaining Elanco Animal Health position as of Q3 2019 after selling out during the quarter.
Legacy Advisors sold 139 Elanco Animal Health shares in Q3 2019, an estimated $5K.
Legacy Advisors first reported a position in Elanco Animal Health in Q2 2019 and held it in 1 quarter.
Legacy Advisors's Elanco Animal Health position peaked at $5K in Q2 2019.
376 funds tracked by Wall St. Rank held Elanco Animal Health as of Q3 2019.

Based on Legacy Advisors's 13F filing for Q3 2019, filed 10 Oct 2019.